China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Randomized controlled clinical study on the effect of Shenfu Injection on clinical outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary PCI'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129490

Registration Time: 2026/08/05

Type: Interventional study

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336748

Published by HT Digital Content Services with permission from Health Daily Digest....